- Home
- Pathology Industry
- Johnson And Johnson Market and Forecasts, May 2012
Industries
- Pathology (13)
- Business Services (11)
- Education and Training (11)
- Drug and Medication (10)
- Drug Discovery and Development (6)
-
- Body Care and Hygiene (4)
- Investment Banking (4)
- Metal and Mineral (4)
- Oral Care Products (4)
- Biotechnology (3)
- Energy (3)
- Healthcare (3)
- In Vitro Diagnostic (3)
- Machine Tool and Equipment (3)
- Medical Facility (3)
- Ophthalmic Devices (3)
- Press (3)
- Agriculture (2)
- Battery (2)
- Business Outsourcing (2)
Top countries
Publication dates
All regions
Johnson And Johnson Market and Forecasts, May 2012
industry reports
country reports
company reports
Johnson and Johnson - Annual Report 2011
- Company report
- January 2011
- 121 pages
... Form 10-k annual report pursuant to section 13 of the securities exchange act of 1934 johnson & johnson (exact name of registrant as specified in its charter) registrant S telephone ...
- Countries: United States
Johnson and Johnson - Investment Analysis, August 2011
- Company report
- August 2011
- 4 pages
... Years old As children take ownership of the purchase typified by a statement such as Mama i don T want johnson baby i M not a baby i want the frog prince one . Understanding ...
- Industries: Body Care and Hygiene
- Countries: China
Johnson and Johnson - Forward Looking Presentation for Year 2011
- Company report
- January 2011
- 51 pages
- by Corporation
... Materially from the expectations and projections of johnson & johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest ...
- Industries: Pathology
- Countries: United States, World
Johnson and Johnson - Company Report for Year 2011
- Company report
- January 2011
- 31 pages
- by Corporation
... Of johnson & johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations ...
- Industries: Pathology
- Countries: United States
Johnson and Johnson - Company Report for Year 2012
- Company report
- May 2012
- 2 pages
- by Corporation
... Served as chief executive officer and president of scios inc., A biopharmaceutical company where he, together with mr. Gryska, led the transaction effort for the successful sale of the company to johnson ...
- Industries: Biotechnology
- Countries: United States
Johnson and Johnson - Company Report for Year 2012
- Company report
- February 2012
- 23 pages
... Is in a sweet spot to ride potentially explosive growth in their demand. Since the exit of the-then drug-eluting stent (des) market leader, johnson & johnson, big has been capturing global market share ...
- Industries: Cardiovascular Devices
Johnson and Johnson - Company Report for Year 2011
- Company report
- October 2011
- 94 pages
... Strong stent technology platform and international presence. johnson & johnson S recent exit of the des market should also benefit biosensors, as biosensors S leading product, biomatrix, compares ...
- Industries: Orthopedic
- Countries: China
Company Report: Medical Equipment and Supply for Year 2011
- Company report
- July 2011
- 97 pages
- by Corporation
... Based software company, that was acquired by the global healthcare exchange, llc, and led the buyouts of ioptex, an intraocular lens manufactu, and two johnson & johnson divestitures, A Company orthodontics ...
- Industries: Medical Equipment and Supply
Company Report: In Vitro Diagnostic in The United States and Australia for Year 2011
- Company report
- December 2011
- 215 pages
... Of johnson & johnson) beneficially held 14,915,400 shares in the company as at december 31, 2011 which represents approximately 9.4% Of the company S shares. The following transactions occurred with life ...
- Industries: In Vitro Diagnostic
- Countries: United States, Australia
Company Report: Drug and Medication in The United States for Year 2012
- Company report
- April 2012
- 34 pages
... Makes up a smaller percentage of their earnings than their competitors johnson and johnson and pfizer, as shown in chart 4 below. They are able to achieve similar results without dedicating as many ...
- Industries: Drug and Medication
- Countries: United States
» Read our Company Profiles
1 Companies for Johnson And JohnsonJohnson and Johnson
United StatesReportlinker.com © Copyright 2012. All rights reserved
